PRKCZ

PRKCZ encodes the atypical protein kinase C-ζ (and its brain-derived constitutively active fragment PKM-ζ), and its principal documented function is the control of cell motility, invasion, and epithelial-mesenchymal transition in cancer through Cdc42-dependent signaling (PMID:20236512, PMID:36077689). In pancreatic adenocarcinoma cells, peptide-based inhibition of PRKCZ abolishes migration, and PRKCZ acts in parallel with RHOA to govern distinct aspects of motility (PMID:20236512). In HPV+ head and neck squamous cell carcinoma, HPV E6 drives DNMT1-mediated promoter hypermethylation that silences PRKCZ, and PRKCZ promotes invasion and EMT by sustaining Cdc42 expression and suppressing E-cadherin, with PRKCZ blockade delaying tumor growth in vivo (PMID:36077689). In the nervous system, the PKM-ζ isoform is induced in the ventral striatum by intermittent ethanol exposure and acts in a negative feedback loop to limit binge-like consumption (PMID:23905844). Contrary to earlier pharmacological models of memory maintenance, germline deletion of both PKC-ζ and PKM-ζ does not impair learning or memory across multiple behavioral paradigms, and the widely used ZIP peptide inhibits PKM-ζ, PKC-ι, and PKC-ζ with similar potency rather than acting specifically on PKM-ζ (PMID:23283171).

1. 2002 Low

   Established that common PRKCZ regulatory variants are functional, addressing whether sequence polymorphisms alter the gene's expression rather than being silent.

   Evidence Allele-specific luciferase reporter assays for two PRKCZ SNPs

   PMID:12905767

   Open questions at the time

   • Single reporter assay without endogenous validation
   • No link to a cellular phenotype or disease
   • No protein-level confirmation
2. 2010 Medium

   Addressed what cellular process PKC-ζ controls in cancer, showing it drives tumor cell motility and invasion in parallel with, but distinct from, RHOA.

   Evidence Cell-permeable PRKCZ/RHOA inhibitory peptides with wound-healing and transwell migration assays in pancreatic adenocarcinoma subclones

   PMID:20236512

   Open questions at the time

   • Peptide inhibitor specificity not orthogonally confirmed by genetic knockdown
   • Downstream effectors of the motility phenotype not defined
   • Single cancer type
3. 2013 High

   Tested the prevailing model that PKM-ζ is the molecular substrate of memory maintenance, and instead showed it is dispensable for memory and that the ZIP inhibitor is not PKM-ζ-specific.

   Evidence Prkcz germline knockout mice across multiple behavioral assays plus in vitro kinase Ki measurements for ZIP, scrambled ZIP, and chelerythrine

   PMID:23283171

   Open questions at the time

   • Possible genetic compensation by other PKC isoforms not excluded
   • Does not identify the true target of ZIP-induced memory effects
4. 2013 Medium

   Defined a CNS function for PKM-ζ, showing it is ethanol-inducible and acts as a brake on binge-like consumption, distinguishing intermittent from continuous access behavior.

   Evidence Western blot of striatal PKM-ζ and ethanol consumption assays in Prkcz−/− versus wild-type mice

   PMID:23905844

   Open questions at the time

   • Molecular substrates of PKM-ζ in the negative feedback loop unknown
   • Circuit-level mechanism not resolved
   • Single lab
5. 2022 Medium

   Connected PRKCZ regulation to viral oncogenesis, showing HPV E6 silences PRKCZ via DNMT1 hypermethylation and that PRKCZ drives invasion/EMT through a Cdc42–E-cadherin axis.

   Evidence Methylation arrays, siRNA knockdown, invasion/wound-healing assays, Western blot, and HPV16-E6/E7 transgenic mouse studies in head and neck squamous cell carcinoma

   PMID:36077689

   Open questions at the time

   • Direct biochemical link between PKC-ζ kinase activity and Cdc42 regulation not established
   • Whether PRKCZ silencing is tumor-suppressive or promoting is context-dependent and unresolved
   • Single lab

• The direct phosphorylation substrates of PKC-ζ/PKM-ζ that mediate its effects on motility, EMT, and ethanol intake remain unidentified, and the mechanistic basis for its Cdc42 regulation is undefined.
• No direct kinase substrate mapped in the corpus
• No structural model of the active kinase or PKM-ζ fragment
• Mechanism linking PKC-ζ to Cdc42 expression unknown